The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 4, 2000, Pages 439-442

  Lange, Ethan M ^a,b   Chen, Hong ^b   Brierley, Kristin ^b   Livermore, Heather ^b   Wojno, Kirk J ^b   Langefeld, Carl D ^a   Lange, Kenneth ^c   Cooney, Kathleen A ^b,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d 7310 CCGC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CANCER GRADING; CANCER SUSCEPTIBILITY; EXON; GENE LOCUS; GENETIC DISORDER; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROSTATE CANCER; X CHROMOSOME;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RISK ASSESSMENT; TRINUCLEOTIDE REPEATS; X CHROMOSOME;

EID: 0034064210     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Narod, S. A., Dupont, A., Cusan, L., Diamond, P., Gomez, J-L., Suhuru, R., and Labrie, F. The impact of family history on early detection of prostate cancer. Nat. Med., 1: 99-101, 1995.
2. Monroe, K. R., Yu, M. C., Kolonel, L. N., Coetzee, G. A., Wilkens, L. R., Ross, R. K., and Henderson, B. E. Evidence of an x-linked or recessive genetic component to prostate cancer risk. Nat. Med., 1: 827-829, 1995.
3. Xu, J., Meyers, D. A., Freije, D., Isaacs, S. D., Wiley, K., Nusskem, D., Ewing, C. M., Wilkens, E., Bujnovszky, P., Bova, G-S., Walsh, P., Isaacs, W. B., Schleutler, J., Matikainen, M., Tammela, T., Visakorpi, T., Kallioniemi, O-P., Berry, R., Schaid, D., French, A., McDonnell, S., Schroeder, J., Blute, M., Thibodeau, S., Gronberg, H., Emanuelsson, M., Damber, J-E., Bergh, A., Jons-son, A., Smith, J., Bailey-Wilson, J. E., Carpten, J. D., Stephan, D., Gillanders, E., Admudson, L., Kainu, T., Freas-Lutz, D., Baffoe-Bonnie, A., Van Aucken, A., Sood, R., Collins, F., Brownstein, M. J., and Trent, J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat. Genet., 20: 175-179, 1998.
4. Lange, E. M., Chen, H., Brierley, K., Perrone, E., Bock, C. H., Gillanders, E., Ray, M. E., and Cooney, K. A. Linkage analysis of 153 prostate cancer families over a 30 cM region containing the putative susceptibility locus HPCX. Clin. Cancer Res., 5: 4013-4020, 1999.
5. Stanford, J. L., Just, J. J., Neal, C. L., Blumenstein, B. A., and Ostrander, E. A. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57: 1194-1198, 1997.
6. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H., and Kantoff, P. W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 3320-3323, 1997.
7. Chamberlain, N. L., Driver, E. D., and Miesfeld, R. L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res., 22: 3181-3186, 1994.
8. Kazemi-Esfarjani, P., Trifiro, M. A., and Pinsky, L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum. Mol. Genet., 4: 523-527, 1995.
9. Choong, C. S., Kemppainen, J. A., Zhou, Z., and Wilson, E. M. Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol. Endocrinol., 10: 1527-1535, 1996.
10. Irvine, R. A., Yu, M. C., Ross, R. K., and Coetzee, G. A. The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res., 55: 1937-1940, 1995.
11. Kruglyak, L., and Lander, E. S. Faster multipoint linkage analysis using Fourier transforms. J. Comput. Biol., 5: 1-7, 1998.
12. Kruglyak, L., Daly, M. J., Reeve-Daly, M. P., and Lander, E. S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet., 58: 1347-1363, 1996.
13. Good, P. Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses. New York: Springer-Verlag, 1994.
14. Gart, J. J., and Zweifel, J. R. On the bias of various estimators of the logit and its variance with application to quantal bioassay. Biometrika, 54: 181-187, 1967.
15. Haldane, J. B. S. The estimation and significance of the logarithm of a ratio of frequencies. Ann. Hum. Genet., 20: 309-311, 1999.
16. Zeger, S. L., and Liang, K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 42: 121-130, 1986.
17. Hakimi, J. M., Schoenberg, M. P., Rondinelli, R. H., Piantadosi, S., and Barrack, E. R. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin. Cancer Res., 3: 1599-1608, 1997.
18. Ross, R. K., Coetzee, G. A., Reichardt, J., Skinner, E., and Henderson, B. E. Does the racial-ethnic variation in prostate cancer risk have a hormonal basis? Cancer (Phila.), 75: 1778-1782, 1995.
19. Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., and Walsh, P. C. Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 150: 797-802, 1993.
20. Rebbeck, T. R., Kantoff, P. W., Krithivas, K., Neuhausen, S., Blackwood, M. A., Godwin, A. K., Daly, M. B., Narod, S. A., Garber, J. E., Lynch, H. T., Weber, B. L., and Brown, M. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am. J. Hum. Genet., 64: 1371-1377, 1999.
21. Ingles, S. A., Ross, R. K., Yu, M. C., Irvine, R. A., La Pera, G., Haile, R. W., and Coetzee, G. A. Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl. Cancer Inst., 89: 166-170, 1997.
22. Stamey, T. A., McNeal, J. E., Yemoto, C. M., Sigal, B. M., and Johnstone, I. M. Biological determinants of cancer progression in men with prostate cancer. J. Am. Med. Assoc., 281: 1395-1400, 1999.
23. Gronberg, H., Isaacs, S. D., Smith, J. R., Carpten, J. D., Bova, G. S., Freije, D., Xu, J., Meyers, D. A., Collins, F. S., Trent, J. M., Walsh, P. C., and Isaacs, W. B. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. J. Am. Med. Assoc., 278: 1251-1255, 1997.
24. Sun, S., Narod, S. A., Aprikian, A., Ghadirian, P., and Labrie, F. Androgen receptor and familial prostate cancer. Nat. Med., 1: 848-849, 1995.